您好, 歡迎來(lái)到化工儀器網(wǎng)! 登錄| 免費(fèi)注冊(cè)| 產(chǎn)品展廳| 收藏商鋪|
行業(yè)產(chǎn)品
中文摘要:
開(kāi)發(fā)有效的金黃色葡萄球菌(S. aureus)疫苗一直是一項(xiàng)具有挑戰(zhàn)性的工作,過(guò)去多年眾多失敗的臨床試驗(yàn)也證明了這一點(diǎn)。在本研究中,我們配制了一種包含高度保守的“兼職"蛋白——丙酮酸脫氫酶復(fù)合物E2亞基(PDHC)的疫苗,并證明該疫苗在多種小鼠疾病模型中能夠誘導(dǎo)針對(duì)流行病學(xué)相關(guān)葡萄球菌菌株的保護(hù)性免疫。雖然抗體應(yīng)答有助于控制細(xì)菌,但在血流感染模型中,抗體對(duì)于保護(hù)性免疫并非必需。相反,疫苗誘導(dǎo)的全身性免疫依賴于γδ T細(xì)胞。此前有研究認(rèn)為,先前接觸過(guò)金黃色葡萄球菌可能會(huì)降低疫苗效力。然而,PDHC誘導(dǎo)的保護(hù)性免疫在先前接觸過(guò)金黃色葡萄球菌的小鼠中仍能促進(jìn)細(xì)菌清除。綜上所述,我們的研究結(jié)果表明,PDHC是一種有前景的、不依賴血清型的候選疫苗,對(duì)甲氧西林敏感和耐甲氧西林的金黃色葡萄球菌分離株均有效。
英文摘要:
Developing an effective Staphylococcus aureus (S. aureus) vaccine has been a challenging endeavor, as demonstrated by numerous failed clinical trials over the years. In this study, we formulated a vaccine containing a highly conserved moonlighting protein, the pyruvate dehydrogenase complex E2 subunit (PDHC), and showed that it induced strong protective immunity against epidemiologically relevant staphylococcal strains in various murine disease models. While antibody responses contributed to bacterial control, they were not essential for protective immunity in the bloodstream infection model. Conversely, vaccine-induced systemic immunity relied on γδ T cells. It has been suggested that prior S. aureus exposure may contribute to the reduction of vaccine efficacy. However, PDHC-induced protective immunity still facilitated bacterial clearance in mice previously exposed to S. aureus. Collectively, our findings indicate that PDHC is a promising serotype-independent vaccine candidate effective against both methicillin-sensitive and methicillin-resistant S. aureus isolates.
論文信息:
論文題目:Conserved moonlighting protein pyruvate dehydrogenase induces robust protection against Staphylococcus aureus infection
期刊名稱:PNAS
時(shí)間期卷:21 (36) e2321939121
在線時(shí)間:2024年8月26日
DOI: 10.1073/pnas.2321939121
產(chǎn)品信息:
貨號(hào):CP-005-005
規(guī)格:5ml+5ml
品牌:Liposoma
產(chǎn)地:荷蘭
名稱:Clodronate Liposomes&Control Liposomes
辦事處:靶點(diǎn)科技
Clodronate Liposomes氯膦酸鹽脂質(zhì)體清除小鼠金黃色葡萄球菌感染模型里巨噬細(xì)胞。荷蘭Liposoma巨噬細(xì)胞清除劑ClodronateLiposomes見(jiàn)刊于PNAS:保守型兼職蛋白丙酮酸脫氫酶誘導(dǎo)針對(duì)金黃色葡萄球菌感染的強(qiáng)效保護(hù)。

Liposoma巨噬細(xì)胞清除劑Clodronate Liposomes氯膦酸二鈉脂質(zhì)體清除巨噬細(xì)胞的材料和方法:
In vivo macrophage depletion
For macrophage depletion, mice were injected intravenously with 100 µL of clodronate liposome (Liposoma) suspension/10 grams of mouse weight 2 d before S. aureus challenge. The same amount of control liposome was administered to the control group.
巨噬細(xì)胞清除材料和方法文獻(xiàn)截圖:

請(qǐng)輸入賬號(hào)
請(qǐng)輸入密碼
請(qǐng)輸驗(yàn)證碼
以上信息由企業(yè)自行提供,信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),化工儀器網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。
溫馨提示:為規(guī)避購(gòu)買(mǎi)風(fēng)險(xiǎn),建議您在購(gòu)買(mǎi)產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。